1,807
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Assessment of knowledge, understanding and awareness of Chinese women clinical staff towards menopause hormone therapy: a survey study

, , &
Article: 2171779 | Received 19 Aug 2022, Accepted 18 Jan 2023, Published online: 11 Feb 2023

References

  • Baber, R.J., Panay, N., and Fenton, A., 2016. 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric: The Journal of the International Menopause Society, 19 (2), 109–150.
  • China Releases First 2010 Census Results, no date. PRB. Available from: https://www.prb.org/resources/china-2010-census-results/ [Accessed: 29 July 2021].
  • Chu, K., et al., 2018. The use and discontinuation of hormone replacement therapy in women in South China. Climacteric: The Journal of the International Menopause Society, 21 (1), 47–52.
  • Çilgin, H., 2019. Predictors of initiating hormone replacement therapy in postmenopausal women: a cross-sectional study. The Scientific World Journal, 2019, e1814804.
  • Collaborative Group on Hormonal Factors in Breast Cancer. 2019. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394 (10204), 1159–1168.
  • Du, L., et al., 2020. Menopausal symptoms and perimenopausal healthcare-seeking behavior in women aged 40–60 years: a community-based cross-sectional survey in Shanghai, China. International Journal of Environmental Research and Public Health, 17 (8), 2640.
  • Grady, D., et al., 1995. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstetrics & Gynecology, 85 (2), 304–313.
  • Huang, K.-E., et al., 2010. The Asian menopause survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas, 65 (3), 276–283.
  • Kongnyuy, E.J., et al., 1999. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviews, (2), CD001018.
  • Lin, L., Feng, P. and Yu, Q., 2020. Attitude and knowledge for menopause management among health professionals in mainland China. Climacteric : The Journal of the International Menopause Society, 23 (6), 614–621.
  • Liu, J. and Eden, J., 2007. Experience and attitudes toward menopause in Chinese women living in Sydney—a cross sectional survey. Maturitas, 58 (4), 359–365.
  • Lumsden, M.A., et al., 2016. Diagnosis and management of menopause: the National Institute of Health and Care Excellence (NICE) guideline. JAMA internal Medicine, 176 (8), 1205–1206.
  • Newton, K.M., et al., 1998. The physician’s role in women’s decision making about hormone replacement therapy. Obstetrics and Gynecology, 92 (4 Pt 1), 580–584.
  • Pan, H.-A., et al., 2002. The perception of menopause among women in Taiwan. Maturitas, 41 (4), 269–274.
  • R Core Team 2020. — European Environment Agency, no date. Available from: https://www.eea.europa.eu/data-and-maps/indicators/oxygen-consuming-substances-in-rivers/r-development-core-team-2006 [Accessed 29 July 2021].
  • Sangi-Haghpeykar, H. and Poindexter, A.N., 2007. Physicians’ views and practices concerning menopausal hormone therapy. Maturitas, 56 (1), 30–37.
  • Shams, T., et al., 2014. SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials. Journal of General Internal Medicine, 29 (1), 204–213.
  • Skouby, S.O., et al., 2005. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Maturitas, 51 (1), 8–14.
  • Studd, J., 2010. Ten reasons to be happy about hormone replacement therapy: a guide for patients. Menopause international, 16 (1), 44–46.
  • Utian, W.H., 2012. A decade post WHI, menopausal hormone therapy comes full circle – need for independent commission. Climacteric: The Journal of the International Menopause Society, 15 (4), 320–325.
  • Weiderpass, E., et al., 1999. Risk of endometrial cancer following estrogen replacement with and without progestins. Journal of the National Cancer Institute, 91 (13), 1131–1137.
  • World Health Organization and United Nations Population Fund, eds., 2007. Women, ageing and health: a framework for action: focus on gender. Paris: World Health Organization. Available from: https://apps.who.int/iris/bitstream/handle/10665/43810/9789241563529_eng.pdf?sequence=1&isAllowed=y.
  • Writing Group for the Women’s Health Initiative Investigators 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA: The Journal of the American Medical Association, 288 (3), 321–333.